Similar articles

• Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.

  Clark J, Hochman R, Rolla AR, Thomas S, Miller DG, Kaldany A, D'Elia JA. Clark J, et al. Clin Exp Dial Apheresis. 1983;7(3):177-90. doi: 10.3109/08860228309076047. Clin Exp Dial Apheresis. 1983. PMID: 6671350
• Prolonged bleeding time associated with moxalactam administration.

  Fishman L, Marsh WR. Fishman L, et al. Neurosurgery. 1984 Jun;14(6):735-6. doi: 10.1227/00006123-198406000-00015. Neurosurgery. 1984. PMID: 6462409
• Coagulopathy associated with the use of moxalactam.

  Pakter RL, Russell TR, Mielke CH, West D. Pakter RL, et al. JAMA. 1982 Sep 3;248(9):1100. JAMA. 1982. PMID: 6213792 No abstract available.
• Determinants of antibiotic-associated hypoprothrombinemia.

  Schentag JJ, Welage LS, Grasela TH, Adelman MH. Schentag JJ, et al. Pharmacotherapy. 1987;7(3):80-6. doi: 10.1002/j.1875-9114.1987.tb03522.x. Pharmacotherapy. 1987. PMID: 3306622 Review.
• The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis.

  Park GH, Kim S, Kim MS, Yu YM, Kim GH, Lee JS, Lee E. Park GH, et al. Int J Environ Res Public Health. 2019 Oct 16;16(20):3937. doi: 10.3390/ijerph16203937. Int J Environ Res Public Health. 2019. PMID: 31623191 Free PMC article.